Skip to main content
. 2007 Jan 22;150(5):633–640. doi: 10.1038/sj.bjp.0707134

Figure 4.

Figure 4

Relaxant effect of abluminal αCGRP in perfused MCA after abluminal application of (a) 10−6M CGRP8–37, (b) 10−7M BIBN4096BS, (c) 2.4 μg ml−1 CGRP antibody and (d) 10−6M NOX-C89. Values are given as means±s.e.m. Statistical analysis by Mann–Whitney U-test, *P<0.01, n=3–7.